BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11801309)

  • 1. Cytogenetic characterization of chromosomal rearrangement in a human vinblastine-resistant CEM cell line: use of comparative genomic hybridization and fluorescence in situ hybridization.
    Struski S; Cornillet-Lefebvre P; Doco-Fenzy M; Dufer J; Ulrich E; Masson L; Michel N; Gruson N; Potron G
    Cancer Genet Cytogenet; 2002 Jan; 132(1):51-4. PubMed ID: 11801309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB; Beck WT; Trent JM
    Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
    Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
    Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.
    Shimizu H; Fukuda T; Ghazizadeh M; Nagashima M; Kawanami O; Suzuki T
    Jpn J Cancer Res; 2002 Aug; 93(8):902-10. PubMed ID: 12716468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization.
    Struski S; Doco-Fenzy M; Trussardi A; Masson L; Gruson N; Ulrich E; Proult M; Jardillier JC; Potron G; Cornillet-Lefebvre P
    Genes Chromosomes Cancer; 2001 Feb; 30(2):136-42. PubMed ID: 11135430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
    Efferth T; Verdorfer I; Miyachi H; Sauerbrey A; Drexler HG; Chitambar CR; Haber M; Gebhart E
    Blood Cells Mol Dis; 2002; 29(1):1-13. PubMed ID: 12482398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
    Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
    Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
    Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
    Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization.
    Nielsen KV; Niebuhr E; Ejlertsen B; Holstebroe S; Madsen MW; Briand P; Mouridsen HT; Bolund L
    Genes Chromosomes Cancer; 1997 Sep; 20(1):30-7. PubMed ID: 9290951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
    Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
    Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
    Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
    Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines.
    Weise A; Liehr T; Efferth T; Kuechler A; Gebhart E
    Cytogenet Genome Res; 2002; 98(2-3):118-25. PubMed ID: 12697993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.
    Pang E; Wong N; Lai PB; To KF; Lau JW; Johnson PJ
    Cancer Genet Cytogenet; 2000 Aug; 121(1):9-16. PubMed ID: 10958934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
    Nieuwint AW; Baas F; Wiegant J; Joenje H
    Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization.
    du Manoir S; Speicher MR; Joos S; Schröck E; Popp S; Döhner H; Kovacs G; Robert-Nicoud M; Lichter P; Cremer T
    Hum Genet; 1993 Feb; 90(6):590-610. PubMed ID: 8444465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
    Obara K; Ghazizadeh M; Shimizu H; Arai R; Tenjin T; Suzuki S; Moriyama Y; Kawanami O
    Int J Oncol; 2002 Feb; 20(2):255-60. PubMed ID: 11788885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.